Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
Caryn Lerman Recruited By Univ. Of Pennsylvania.
BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
Impath Buys Clinical Studies Support Services Network.
MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
Vasopermeation Technology Awarded Patent For CA Firm.
FDA Approves Xeloda For Breast Cancer Treatment.
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast